# MCPI: Integrating Multimodal Data for Enhanced Prediction of Compound Protein Interactions

arXiv: https://arxiv.org/abs/2306.08907 · HTML: https://mlsanity.com/paper/2306.08907/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 13 of its 71 references that are in the map.
- First posted on arXiv 15 Jun 2023.

## Builds on (most cited first, 13 of 13)

- [Deep Residual Learning for Image Recognition](https://mlsanity.com/paper/1512.03385/) (2015)
- [Adam: A Method for Stochastic Optimization](https://mlsanity.com/paper/1412.6980/) (2014)
- [Efficient Estimation of Word Representations in Vector Space](https://mlsanity.com/paper/1301.3781/) (2013)
- [Learning Phrase Representations using RNN Encoder-Decoder for Statistical Machine Translation](https://mlsanity.com/paper/1406.1078/) (2014)
- [node2vec: Scalable Feature Learning for Networks](https://mlsanity.com/paper/1607.00653/) (2016)
- [Spatial Pyramid Pooling in Deep Convolutional Networks for Visual Recognition](https://mlsanity.com/paper/1406.4729/) (2014)
- [Language Modeling with Gated Convolutional Networks](https://mlsanity.com/paper/1612.08083/) (2016)
- [Modeling polypharmacy side effects with graph convolutional networks](https://mlsanity.com/paper/1802.00543/) (2018)
- [DeepDTA: Deep Drug-Target Binding Affinity Prediction](https://mlsanity.com/paper/1801.10193/) (2018)
- [DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences](https://mlsanity.com/paper/1811.02114/) (2018)
- [WideDTA: prediction of drug-target binding affinity](https://mlsanity.com/paper/1902.04166/) (2019)
- [Deep learning for drug repurposing: methods, databases, and applications](https://mlsanity.com/paper/2202.05145/) (2022)
- [Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning](https://mlsanity.com/paper/2005.10831/) (2020)

## Abstract (arXiv)

The identification of compound-protein interactions (CPI) plays a critical role in drug screening, drug repurposing, and combination therapy studies. The effectiveness of CPI prediction relies heavily on the features extracted from both compounds and target proteins. While various prediction methods employ different feature combinations, both molecular-based and network-based models encounter the common obstacle of incomplete feature representations. Thus, a promising solution to this issue is to fully integrate all relevant CPI features. This study proposed a novel model named MCPI, which is designed to improve the prediction performance of CPI by integrating multiple sources of information, including the PPI network, CCI network, and structural features of CPI. The results of the study indicate that the MCPI model outperformed other existing methods for predicting CPI on public datasets. Furthermore, the study has practical implications for drug development, as the model was applied to search for potential inhibitors among FDA-approved drugs in response to the SARS-CoV-2 pandemic. The prediction results were then validated through the literature, suggesting that the MCPI model could be a useful tool for identifying potential drug candidates. Overall, this study has the potential to advance our understanding of CPI and guide drug development efforts.